Cancer Cell Therapy

At the moment, these are patient bespoke therapies. What we try to do is make them available off the peg or off the shelf. We have to add in some extra engineering steps which means that they can be infused into multiple recipients without the need for very close matching. So all of that together means the cells will have a free run for two to three weeks after infusion in a patient before really being challenged by the patient's own immune system. And we think that's actually long enough to get a deep clearance of leukemia.